A quantitative bifunctional in vitro potency assay for botulinum neurotoxin serotype A

Journal of Pharmacological and Toxicological Methods
Richard W GregoryCurtis Ruegg

Abstract

Botulinum neurotoxin type A (BoNTA) is one of seven serotypes produced by Clostridium botulinum (types A thru G) and is the serotype most widely used to treat both cosmetic and medical conditions. Potency for botulinum toxin preparations is expressed in mouse LD50 units. There is a need to develop a non-animal based replacement for this potency assay. An in vitro potency assay measuring BoNTA activity has been developed that addresses both BoNTA heavy chain binding to its cell receptor SV2C and BoNTA light chain enzymatic activity in cleaving SNAP-25, an intracellular protein essential in neurotransmitter release. This bifunctional assay utilizes a 96 well microtiter format and well defined reagents. Assay characterization determined that the relative standard deviation for intermediate precision was less than 10%. The assay standard curve covers the range of BoNTA concentrations from 0.0624 to 32 ng/mL. Specificity was demonstrated with purified BoNTA heavy chain which inhibited the activity in a dose dependent manner. A correlation between this bifunctional assay and the mouse LD50 potency assay was demonstrated.

References

Apr 23, 1999·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R PellizzariC Montecucco
May 5, 2004·The Journal of Biological Chemistry·Andreas RummelThomas Binz
Dec 2, 2005·Emerging Infectious Diseases·John R BarrDavid L Ashley
Mar 18, 2006·Science·Min DongEdwin R Chapman
Sep 26, 2008·Molecular Biology of the Cell·Min DongEdwin R Chapman
Apr 14, 2009·Toxicon : Official Journal of the International Society on Toxinology·Michael R Baldwin, Joseph T Barbieri
Sep 23, 2010·Biochemical and Biophysical Research Communications·Yanfeng ZhangSusan M Varnum
Jan 11, 2011·Analytical Biochemistry·Daniel R RugeWard C Tucker
Mar 13, 2012·Analytical Biochemistry·Yvonne Y B LiuRussell G A Jones

❮ Previous
Next ❯

Related Concepts

Related Feeds

Botulism (ASM)

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Botulism

Botulism is a rare but serious paralytic illness caused by a nerve toxin that is produced by the bacterium clostridium botulinum. Discover the latest research on botulism here.

Related Papers

Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
Hai-Yan JiangPeiying Yu
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
Thomas SychaEduard Auff
Journal of Cosmetic and Laser Therapy : Official Publication of the European Society for Laser Dermatology
Koen de Boulle
Journal of Neurology, Neurosurgery, and Psychiatry
J J M KruisdijkJ D Speelman
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]
Ada R Trindade de AlmeidaRosana Boraso
© 2021 Meta ULC. All rights reserved